| SC 13G/A | 2024-02-14 | RA CAPITAL MANAGEMENT, L.P. | CureVac N.V. | 2,744,270 | 1.2% | EDGAR |
| SC 13G/A | 2024-02-06 | GSK plc | CureVac N.V. | 16,591,937 | 7.4% | EDGAR |
| SC 13G | 2023-03-27 | RA CAPITAL MANAGEMENT, L.P. | CureVac N.V. | 12,245,955 | 5.5% | EDGAR |
| SC 13D/A | 2023-02-24 | KfW | CureVac N.V. | 114,190,046 | 51.4% | EDGAR |
| SC 13D/A | 2023-02-24 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 70,181,760 | 31.6% | EDGAR |
| SC 13D/A | 2023-02-24 | Hettich Christof | CureVac N.V. | 302,268 | 0.1% | EDGAR |
| SC 13D/A | 2023-02-24 | von Bohlen und Halback Friedrich | CureVac N.V. | 469,764 | 0.2% | EDGAR |
| SC 13D/A | 2023-02-24 | Hothum Mathias | CureVac N.V. | 95,504 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-13 | KfW | CureVac N.V. | 115,601,965 | 52.1% | EDGAR |
| SC 13D/A | 2022-11-14 | Hettich Christof | CureVac N.V. | 1,019,235 | 0.5% | EDGAR |
| SC 13D/A | 2022-11-14 | von Bohlen und Halback Friedrich | CureVac N.V. | 499,944 | 0.3% | EDGAR |
| SC 13D/A | 2022-11-14 | Hothum Mathias | CureVac N.V. | 95,504 | 0.3% | EDGAR |
| SC 13D/A | 2022-11-14 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 70,846,532 | 37.9% | EDGAR |
| SC 13D/A | 2022-06-24 | Hettich Christof | CureVac N.V. | 1,019,235 | 0.5% | EDGAR |
| SC 13D/A | 2022-06-24 | von Bohlen und Halback Friedrich | CureVac N.V. | 499,944 | 0.3% | EDGAR |
| SC 13D/A | 2022-05-05 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 82,963,501 | 44.3% | EDGAR |
| SC 13D | 2022-05-05 | von Bohlen und Halback Friedrich | CureVac N.V. | 499,944 | 0.3% | EDGAR |
| SC 13D | 2022-05-05 | Hettich Christof | CureVac N.V. | 1,019,235 | 0.5% | EDGAR |
| SC 13D | 2022-05-05 | Hothum Mathias | CureVac N.V. | 495,504 | 0.3% | EDGAR |
| SC 13D/A | 2022-03-17 | dievini Hopp BioTech holding GmbH & Co KG | CureVac N.V. | 84,868,173 | 45.4% | EDGAR |